Small Molecule Antibody

The company focuses on yeast molecular biology technology as its research and development direction, and relies on independent innovative technology platforms such as "high-throughput yeast interaction technology", "yeast secretion expression", and "yeast display" to provide a full chain and scenario application solution for yeast

CONTACT OUR EXPERTS

Ruiyuan Biotechnology

Nanobody Screening (Nuclear System)

The customized Nanobody Screening Nuclear System can quickly and efficiently screen and identify nanobodies that function in the nucleus The antigen-binding capacity of nanobodies is similar to conventional antibodies for three reasons. First, the complementarity-determining region 3 (CDR3) of nanobodies is similar to or even longer than that of the human VH domain (variable domain of heavy immunoglobulin chain).

See More

FAQ

Do you have a question?

Do you have a question for us?

contact our experts

Explore More →

Any question? Get in touch with us!